ABOUT US OUR PRODUCTS & PIPELINE BUSINESS DEVELOPMENT OUR INVESTORS PRESS ROOM CONTACT US
 
KEY PERSONNEL

BOARD OF DIRECTORS

DEVELOPMENT ADVISORY BOARD
 

Dr Mark Payton
Chief Executive Officer & Chief Scientific Officer

Dr Mike Perkins
Director of Development

Richard Onyett
Commercial Director

Dr Mick Hunter
Director of Drug Discovery

Dr Roy Pettipher
Director of Pharmacology

Paul Foster
Finance Director

  Richard Onyett
Commercial Director

Richard Onyett joined Oxagen in July 2006. He was previously Commercial Director for KuDos Pharmaceuticals Ltd (2001-2006) responsible for all Corporate and Business Development and Marketing activities within the Company and was directly involved in a major private equity fund raising in 2002 (£29.5m)

Other roles include Senior Vice President Business Development and Marketing, Epidauros Biotechnologie AG (1999-2001) and Senior Vice President, Corporate Development at Anthra Pharmaceuticals, Inc. (1997-1999), a company specialising in cancer drug development.
Prior to that he ran his own consultancy, before which he worked with SmithKlineBeecham for nine years, and ICI Pharmaceuticals, now AstraZeneca.

Oxagen Limited, 91 Milton Park, Abingdon, Oxfordshire OX14 4RY   t : +44(0) 1235 443300  f: +44(0) 1235 443301  e: oxagen@oxagen.co.uk